PROCEPT BioRobotics Corporation (PRCT)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.19B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,151,256
- 52-week high
- —
- 52-week low
- —
- Open
- $19.02
- Day high
- $19.54
- Day low
- $18.61
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $308.05M | -$95.57M | -$1.72 |
| 2024 | $224.5M | -$91.41M | -$1.75 |
| 2023 | $136.19M | -$105.9M | -$2.24 |
| 2022 | $75.01M | -$87.15M | -$1.96 |
| 2021 | $34.47M | -$59.85M | -$3.63 |
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
- CEO
- Larry L. Wood
- Employees
- 756
- Country
- US
- IPO date
- Sep 15, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is PROCEPT BioRobotics Corporation's stock price today?
- PRCT is trading at $19.22 as of Jul 20, 2026.
- What is PROCEPT BioRobotics Corporation's market cap?
- PROCEPT BioRobotics Corporation (PRCT) has a market capitalization of $1.19B.
- Does PROCEPT BioRobotics Corporation pay a dividend?
- PROCEPT BioRobotics Corporation did not pay a dividend in its most recent reported fiscal year.
- What sector is PROCEPT BioRobotics Corporation in?
- PROCEPT BioRobotics Corporation operates in the Healthcare sector.